When a Drug Discount Program Becomes a Hospital Profit Engine, Patients Lose

When a Drug Discount Program Becomes a Hospital Profit Engine, Patients Lose

Coalition of State Rheumatology Organizations 340B Drug Pricing Program By Dr. Leyka Barbosa Similar to many of my colleagues in medicine, I see firsthand how vitally important access to affordable medication is for patients battling autoimmune diseases, such as rheumatoid arthritis and lupus. Many of my patients rely on costly biologic therapies to manage their conditions and maintain their quality of life. Yet, an essential federal program des…